The Sixth Circuit Court of Appeals has upheld the conviction of Dr. Bernard Shelton, a Michigan physician, for unlawfully distributing controlled substances. This ruling, made on July 1, 2026, affects not only Shelton but also sets a precedent for how medical professionals prescribe medications, particularly controlled substances.
Dr. Shelton was convicted on twenty-one counts of unlawfully distributing controlled substances to patients, some of whom he did not examine. His actions raised significant concerns about drug abuse and the responsibilities of medical practitioners in prescribing medications. The court's decision emphasizes the importance of adhering to medical standards and the consequences of failing to do so.
Background
Dr. Bernard Shelton operated a medical clinic in St. Clair Shores, Michigan, where he specialized in internal medicine. He was authorized to prescribe controlled substances by the Drug Enforcement Administration (DEA). However, over time, Shelton's practice came under scrutiny as he prescribed a staggering number of medications, often to patients who showed signs of drug-seeking behavior rather than legitimate medical needs.
The case against Shelton began when DEA agents visited his clinic in September 2015 to inquire about his prescribing practices. Following this visit, there was a notable decrease in the number of prescriptions he issued, indicating that he was aware of the scrutiny. Despite this, he continued to prescribe controlled substances to patients with red flags indicating potential misuse, leading to a tragic overdose death of one patient, James Hoey, in January 2016.
The Ruling
The Sixth Circuit, consisting of Judges Stephanie Dawkins Davis, Kevin G. Ritz, and Whitney D. Hermandorfer, ruled that there was sufficient evidence to uphold Shelton's conviction. The court found that the jury had enough information to conclude that Shelton knowingly distributed medications without a legitimate medical purpose. The opinion stated, "Ample evidence supports his conviction; the jury instructions were not confusing, misleading, or otherwise infirm; and the mask mandate was not reversible error."
The court also addressed Shelton's challenges regarding the jury instructions and the authority of the Attorney General to regulate drug dispensing. It concluded that the jury was correctly instructed on the necessary standards for determining whether Shelton's actions were unauthorized. The ruling emphasized that the evidence presented at trial clearly indicated that Shelton's prescribing practices were outside the usual course of medical practice.
Impact
This ruling has significant implications for medical professionals across the country. It reinforces the legal standards that physicians must adhere to when prescribing controlled substances. The court's decision highlights the importance of evaluating patients thoroughly, considering their medical history, and being vigilant against signs of drug abuse.
Furthermore, the ruling may deter other healthcare providers from engaging in similar practices, as it sets a clear precedent for the consequences of failing to adhere to medical guidelines. The case serves as a reminder that medical professionals can face severe legal repercussions for negligence and misconduct in their prescribing practices.
What's Next
Dr. Shelton has the option to appeal the Sixth Circuit's decision to the U.S. Supreme Court, although it is unclear whether he will pursue this route. The outcome of this case may influence similar cases involving medical professionals and their prescribing practices in the future.